NCT05188131View on ClinicalTrials.gov

Acute Neuroendocrine Response to Intravenous Infusion of Diclofenac Sodium

PHASE4CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 1, 2021

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Hypopituitarism
Interventions
DRUG

Intravenous Infusion of Diclofenac Sodium

Intravenous Infusion of Diclofenac Sodium is administered at the dose of 75 mg, diluted in 100 ml of isotonic saline, over 15 minutes.

DRUG

Intravenous Infusion of Placebo

Intravenous Infusion of Placebo (represented by 100 ml of isotonic saline) is administered over 15 minutes.

Trial Locations (1)

10126

AOU Città della Salute e della Scienza, Turin

All Listed Sponsors
lead

A.O.U. Città della Salute e della Scienza

OTHER

NCT05188131 - Acute Neuroendocrine Response to Intravenous Infusion of Diclofenac Sodium | Biotech Hunter | Biotech Hunter